MBX Biosciences Opens At $23, IPO Priced At $16

September 13, 2024

MBX Biosciences (MBX) Opens At $23, IPO Priced At $16

This post appeared first on investing.com

(Reuters) – Stellantis (NYSE:STLA) has reversed its decision to lay off about 1,100 employees at...

By Makiko Yamazaki TOKYO (Reuters) – Top Japanese finance officials said on Friday the government...

ADDIS ABABA (Reuters) – French President Emmanuel Macron expressed full support on Saturday for...

Investing.com — Food prices, while no longer rising as rapidly, is expected to remain at the...

FRANKFURT (Reuters) – Volkswagen (ETR:VOWG_p) on Friday said it had agreed with unions to cut...

MEXICO CITY (Reuters) – Mexican President Claudia Sheinbaum expects Congress to approve a ban...